COVID-19 患者中确诊的黄曲霉菌性肺曲霉病：病例报告及文献复习。
Proven Aspergillus flavus pulmonary aspergillosis in a COVID-19 patient: A case report and review of the literature.
机构信息
Department of Infectious Diseases and Tropical Medicine, Imam Khomeini Hospital complex, Tehran University of Medical Sciences, Tehran, Iran.
Department of Internal Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
出版信息
Mycoses. 2021 Aug;64(8):809-816. doi: 10.1111/myc.13255. Epub 2021 Mar 2.
Abstract
Severe COVID-19 patients complicated with aspergillosis are increasingly reported. We present a histopathological proven case of fatal COVID-19-associated pulmonary aspergillosis (CAPA), due to Aspergillus flavus. This report and existing published literature indicate diagnostic challenges and poor outcomes of CAPA in ICU patients.
摘要
严重 COVID-19 患者并发曲霉病的报道越来越多。我们报告了一例经组织病理学证实的 COVID-19 相关肺曲霉病（CAPA）致死病例，由黄曲霉引起。本报告和现有已发表文献表明，ICU 患者 CAPA 的诊断存在挑战，且预后较差。
相似文献
1
Proven Aspergillus flavus pulmonary aspergillosis in a COVID-19 patient: A case report and review of the literature.COVID-19 患者中确诊的黄曲霉菌性肺曲霉病：病例报告及文献复习。
Mycoses. 2021 Aug;64(8):809-816. doi: 10.1111/myc.13255. Epub 2021 Mar 2.
2
COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series.COVID-19 相关肺曲霉病：一项前瞻性单中心双病例系列研究。
Mycoses. 2021 Apr;64(4):457-464. doi: 10.1111/myc.13254. Epub 2021 Feb 16.
3
Case Report: Chronic Cavitatory Pulmonary Aspergillosis after COVID-19.病例报告：COVID-19 后慢性空洞性肺曲霉病。
Am J Trop Med Hyg. 2021 Nov 24;106(1):105-107. doi: 10.4269/ajtmh.21-0701.
4
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.新型冠状病毒肺炎相关肺曲霉病诊断与临床管理特别工作组报告
Intensive Care Med. 2021 Aug;47(8):819-834. doi: 10.1007/s00134-021-06449-4. Epub 2021 Jun 23.
5
Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient.免疫功能正常患者的侵袭性曲霉病和冠状病毒病致死。
Emerg Infect Dis. 2020 Jul;26(7):1636-1637. doi: 10.3201/eid2607.201603. Epub 2020 Jun 21.
6
COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.新型冠状病毒肺炎相关混合霉菌感染：1例曲霉病和毛霉病病例报告及文献综述
J Mycol Med. 2022 Mar;32(1):101231. doi: 10.1016/j.mycmed.2021.101231. Epub 2021 Nov 26.
7
Comparison of influenza- and COVID-19-associated pulmonary aspergillosis in China.比较中国流感和新冠相关侵袭性肺曲霉病。
Eur J Clin Microbiol Infect Dis. 2024 Apr;43(4):683-692. doi: 10.1007/s10096-024-04772-4. Epub 2024 Feb 7.
8
COVID-19-associated pulmonary aspergillosis is associated with increased in-hospital mortality and prolonged SARS-CoV-2 viral shedding.COVID-19 相关肺曲霉病与住院死亡率增加和 SARS-CoV-2 病毒脱落时间延长相关。
J Formos Med Assoc. 2022 Dec;121(12):2617-2625. doi: 10.1016/j.jfma.2022.07.006. Epub 2022 Aug 8.
9
10
Invasive pulmonary aspergillosis in patients with acute respiratory syndrome by COVID-19.COVID-19 相关急性呼吸窘迫综合征患者侵袭性肺曲霉病。
Rev Esp Anestesiol Reanim (Engl Ed). 2022 Jan;69(1):48-53. doi: 10.1016/j.redare.2021.02.007. Epub 2022 Jan 7.
引用本文的文献
1
Genome-Wide Exploration of Thiamin Pyrophosphate Riboswitches in Medically Relevant Fungi Reveals Diverse Distribution and Implications for Antimicrobial Drug Targeting.医学相关真菌中硫胺素焦磷酸核糖开关的全基因组探索揭示了其多样分布及对抗菌药物靶向的意义。
ACS Omega. 2024 Dec 10;9(51):50134-50146. doi: 10.1021/acsomega.4c00158. eCollection 2024 Dec 24.
2
Endocarditis caused by Aspergillus fumigatus in a patient 9 months after COVID-19 infection recovery: a case report and review of the literature.COVID-19 感染康复 9 个月后曲霉菌引起的心内膜炎：病例报告及文献复习。
J Med Case Rep. 2023 Dec 19;17(1):519. doi: 10.1186/s13256-023-04252-x.
3
Mucociliary transport deficiency and disease progression in Syrian hamsters with SARS-CoV-2 infection.SARS-CoV-2 感染的叙利亚仓鼠的黏液纤毛转运缺陷和疾病进展。
JCI Insight. 2023 Jan 10;8(1):e163962. doi: 10.1172/jci.insight.163962.
4
Genomic and Phenotypic Trait Variation of the Opportunistic Human Pathogen Aspergillus flavus and Its Close Relatives.机会性人类病原体黄曲霉及其近亲的基因组和表型特征变异。
Microbiol Spectr. 2022 Dec 21;10(6):e0306922. doi: 10.1128/spectrum.03069-22. Epub 2022 Nov 1.
5
Comparative risk assessment of COVID-19 associated mucormycosis and aspergillosis: A systematic review.新型冠状病毒肺炎相关毛霉菌病和曲霉病的比较风险评估：一项系统评价
Health Sci Rep. 2022 Aug 18;5(5):e789. doi: 10.1002/hsr2.789. eCollection 2022 Sep.
6
COVID-19-associated fungal infections in Iran: A systematic review.伊朗与 COVID-19 相关的真菌感染：一项系统综述。
PLoS One. 2022 Jul 11;17(7):e0271333. doi: 10.1371/journal.pone.0271333. eCollection 2022.
7
Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis.新型冠状病毒肺炎相关肺曲霉病的临床及影像学特征
Diagnostics (Basel). 2022 May 11;12(5):1201. doi: 10.3390/diagnostics12051201.
8
An overview of COVID-19 related to fungal infections: what do we know after the first year of pandemic?新型冠状病毒肺炎相关真菌感染概述：大流行一年后我们了解了哪些？
Braz J Microbiol. 2022 Jun;53(2):759-775. doi: 10.1007/s42770-022-00704-6. Epub 2022 Mar 21.
9
Mucociliary Transport Deficiency and Disease Progression in Syrian Hamsters with SARS-CoV-2 Infection.感染SARS-CoV-2的叙利亚仓鼠的黏液纤毛运输缺陷与疾病进展
bioRxiv. 2022 Jan 18:2022.01.16.476016. doi: 10.1101/2022.01.16.476016.
10
Invasive Fungal Infections Complicating COVID-19: A Narrative Review.新型冠状病毒肺炎合并侵袭性真菌感染：一篇叙述性综述
J Fungi (Basel). 2021 Oct 29;7(11):921. doi: 10.3390/jof7110921.
本文引用的文献
1
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.定义和管理新型冠状病毒肺炎相关肺曲霉病：2020年欧洲临床微生物与感染性疾病学会/国际人类与动物真菌学会研究和临床指南共识标准
Lancet Infect Dis. 2021 Jun;21(6):e149-e162. doi: 10.1016/S1473-3099(20)30847-1. Epub 2020 Dec 14.
2
Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity.COVID-19 时代的侵袭性肺曲霉病：一种预期的新实体。
Mycoses. 2021 Feb;64(2):132-143. doi: 10.1111/myc.13213. Epub 2020 Nov 29.
3
Coronavirus Disease 2019 (COVID-19) in a Patient with Disseminated Histoplasmosis and HIV-A Case Report from Argentina and Literature Review.一名播散性组织胞浆菌病合并艾滋病患者的2019冠状病毒病（COVID-19）——来自阿根廷的病例报告及文献综述
J Fungi (Basel). 2020 Nov 10;6(4):275. doi: 10.3390/jof6040275.
4
COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory.COVID-19 相关侵袭性曲霉病：来自英国国家真菌学参考实验室的数据。
J Clin Microbiol. 2020 Dec 17;59(1). doi: 10.1128/JCM.02136-20.
5
Aspergillosis Complicating Severe Coronavirus Disease.曲霉病合并严重冠状病毒病。
Emerg Infect Dis. 2021 Jan;27(1):18-25. doi: 10.3201/eid2701.202896. Epub 2020 Oct 21.
6
Classification of aerosol-generating procedures: a rapid systematic review.气溶胶产生程序分类：快速系统综述。
BMJ Open Respir Res. 2020 Oct;7(1). doi: 10.1136/bmjresp-2020-000730.
7
Fatal Invasive Pulmonary Aspergillosis in COVID-19 Patient with Acute Myeloid Leukemia in Iran.伊朗 COVID-19 合并急性髓系白血病患者的致命性侵袭性肺曲霉病。
Mycopathologia. 2020 Dec;185(6):1077-1084. doi: 10.1007/s11046-020-00493-2. Epub 2020 Oct 3.
8
Mucormycosis with orbital compartment syndrome in a patient with COVID-19.COVID-19 患者合并眼窝间隔综合征的毛霉菌病。
Am J Emerg Med. 2021 Apr;42:264.e5-264.e8. doi: 10.1016/j.ajem.2020.09.032. Epub 2020 Sep 16.
9
Putative invasive pulmonary aspergillosis in critically ill patients with COVID-19: An observational study from New York City.COVID-19 重症患者疑似侵袭性肺曲霉病：来自纽约市的观察性研究。
Mycoses. 2020 Dec;63(12):1368-1372. doi: 10.1111/myc.13185. Epub 2020 Oct 1.
10
Bronchoscopy safety precautions for diagnosing COVID-19 associated pulmonary aspergillosis-A simulation study.COVID-19 相关肺曲霉病诊断用支气管镜安全防范措施——一项模拟研究。
Mycoses. 2021 Jan;64(1):55-59. doi: 10.1111/myc.13183. Epub 2020 Sep 26.
Zotero 插件